STAT3 and breast cancer: To this end, we examined the METABRIC breast cancer dataset [41] for the expression of a signature composed of the genes belonging to the IL-6 or the WNT non-canonical pathways characterized by in vivo binding of both STAT3 and SP1, as identified above, denominated the SP1-S3 signature (Tables S2 and S3).